Inventor

FENSTER ERIK

US29 patents

⚠️ This page may combine multiple inventors who share the name “FENSTER ERIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FENSTER ERIK

THERAVANCE BIOPHARMA R&D IP LLC

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Neprilysin inhibitors

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Neprilysin inhibitors

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Substituted pyridines and methods of use

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Neprilysin inhibitors

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

Fused pyrimidine pyridinone compounds as JAK inhibitors

HUGHES ADAM D

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

FENSTER ERIK

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors